Cargando…

The Course of COVID-19 in Inflammatory Bowel Disease: Protective Role of TNF Antagonists

Detalles Bibliográficos
Autores principales:	Cappello, Maria, Busacca, Anita, Guida, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the AGA Institute 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832066/ https://www.ncbi.nlm.nih.gov/pubmed/32645320 http://dx.doi.org/10.1053/j.gastro.2020.06.087

Ejemplares similares

Perception of the Role of Food and Dietary Modifications in Patients with Inflammatory Bowel Disease: Impact on Lifestyle
por: Guida, Laura, et al.
Publicado: (2021)

AF.53 THE LEGACY OF COVID-19 PANDEMICS: REMOTE MONITORING OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE AS AN EFFECTIVE MANAGEMENT STRATEGY
por: Busacca, A., et al.
Publicado: (2021)

TNFα-Antagonist Use and Mucosal Inflammation Are Associated with Increased Intestinal Expression of SARS-CoV-2 Host Protease TMPRSS2 in Patients with Inflammatory Bowel Disease
por: Bangma, Amber, et al.
Publicado: (2021)

Roles of Clinical Pharmacists in Caring for Patients With Inflammatory Bowel Disease During COVID-19
por: Bhat, Shubha, et al.
Publicado: (2021)

Low frequency of COVID-19 in inflammatory bowel diseases
por: Marafini, Irene, et al.
Publicado: (2020)

COVID-19 vaccinations in patients with inflammatory bowel disease
por: Kumar, Aditi, et al.
Publicado: (2020)

Noninvasive monitoring of inflammatory bowel disease in the post COVID-19 era
por: Nardone, Olga Maria, et al.
Publicado: (2020)

Prevention of COVID-19 in patients with inflammatory bowel disease in Wuhan, China
por: An, Ping, et al.
Publicado: (2020)

Balancing Risks and Benefits in Inflammatory Bowel Disease Patients during the COVID-19 Pandemic
por: Kotze, Paulo Gustavo, et al.
Publicado: (2021)

COVID-19 Vaccination in Patients with Inflammatory Bowel Disease: A Survey from China
por: Dai, Cong, et al.
Publicado: (2021)

Impact of Medication Discontinuation on Patients With Inflammatory Bowel Disease During the COVID-19 Outbreak
por: Chen, Junrong, et al.
Publicado: (2021)

Vedolizumab use after failure of TNF-α antagonists in children and adolescents with inflammatory bowel disease
por: Schneider, Anna-Maria, et al.
Publicado: (2018)

Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry
por: Brenner, Erica J., et al.
Publicado: (2020)

Management of patients with inflammatory bowel disease and outcomes during the first wave of the Covid-19 pandemic
por: Viola, Anna, et al.
Publicado: (2021)

Viral screening before initiation of biologics in patients with inflammatory bowel disease during the COVID-19 outbreak
por: Zingone, Fabiana, et al.
Publicado: (2020)

The management of inflammatory bowel diseases in the era of COVID-19 pandemic: When “non-urgent” does not mean “deferrable”
por: Pugliese, Daniela, et al.
Publicado: (2020)

Could Patients With Inflammatory Bowel Disease Treated With Immunomodulators or Biologics Be at Lower Risk for Severe Forms of COVID-19?
por: Macaluso, Fabio Salvatore, et al.
Publicado: (2021)

Should Patients With Inflammatory Bowel Disease Be Tested for Active COVID-19 Before Starting a Biological Treatment?
por: Barberio, Brigida, et al.
Publicado: (2021)

COVID-19 Vaccination and Inflammatory Bowel Disease: Desired Antibody Responses, Future Directions, and a Note of Caution
por: Levine, Irving, et al.
Publicado: (2022)

Reply to Comment on: “Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease”
por: Macaluso, Fabio Salvatore, et al.
Publicado: (2023)

The Adherence to Infusible Biologic Therapies in Inflammatory Bowel Disease Patients during the COVID-19 Pandemic: Is It Really a Problem?
por: Barberio, Brigida, et al.
Publicado: (2021)

Severe Inflammatory Bowel Disease Flares and COVID-19: Expand the Gastroenterology–Surgery Team to Include an Infectious Disease Specialist
por: Bezzio, Cristina, et al.
Publicado: (2021)

The Courage to Return to Everyday Life at the Time of COVID-19: The Point of View of Inflammatory Bowel Disease Patients Needing Endoscopy
por: Mocciaro, Filippo, et al.
Publicado: (2021)

Therapeutic adherence recorded in the outpatient follow-up of inflammatory bowel diseases in a referral center: Damages of COVID-19()
por: Pellegrino, Raffaele, et al.
Publicado: (2022)

The future of robotic surgery for inflammatory bowel diseases
por: Gul, Fahad, et al.
Publicado: (2022)

Inflammatory bowel disease in Lebanon: a plea for help
por: Mourad, Fadi H, et al.
Publicado: (2022)

CME Exam 1: Corticosteroids, But Not TNF Antagonists, Are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an International Registry
Publicado: (2020)

Patient-Preferences Favoring Treatment Discontinuation Are Reduced With Vedolizumab and Ustekinumab Compared With TNF Antagonists in Inflammatory Bowel Disease
por: Kumar, Anand, et al.
Publicado: (2020)

Fecal calprotectin levels in COVID-19: Lessons from a systematic review on its use in inflammatory bowel disease during the pandemic
por: Jena, Anuraag, et al.
Publicado: (2021)

Can influenza vaccine modify COVID-19 clinical course?
por: Eldanasory, Omar Abdelhay, et al.
Publicado: (2020)

Adalimumab for treatment of very early onset inflammatory bowel disease
por: Xie, Yao, et al.
Publicado: (2019)

Telemedicine: A promising future for inflammatory bowel disease management
por: Fazal, Faizan, et al.
Publicado: (2022)

Clinical Course and Outcomes of 344 Intensive Care Patients with COVID-19
por: Wang, Yang, et al.
Publicado: (2020)

Urgent surgery for inflammatory bowel diseases during the COVID-19 outbreak in a high incidence area - Experience from a high-volume centre
por: Botti, Fiorenzo, et al.
Publicado: (2020)

Non-Hodgkin's Lymphoma: An Important Differential Diagnosis in Inflammatory Bowel Disease
por: Saad-Hossne, Rogerio, et al.
Publicado: (2018)

Therapeutic Decisions in Inflammatory Bowel Disease in the SARS-Cov-2 Pandemic
por: Brain, Oliver, et al.
Publicado: (2021)

SARS-CoV-2 vaccination for patients with inflammatory bowel disease
por: Garrido, Hannah M Garcia, et al.
Publicado: (2021)

Washed microbiota transplantation improves the fertility of patients with inflammatory bowel disease
por: Zhao, Zhaoyang, et al.
Publicado: (2022)

The Importance of Screening for Inflammatory Bowel Disease in Patients with Psoriasis and Psoriatic Arthritis
por: Aldana, Isabella, et al.
Publicado: (2022)

Anti-TNF Withdrawal in Inflammatory Bowel Disease
por: Torres, Joana, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1bfof1p64k5j6ps2c24p5pg2g8